Sangart Inc., a San Diego-based developer of an artificial blood substitute, has raised $50 million in additional Series F funding. This brings the round total to $100 million, and the company’s total venture capitalization to over $170 million. No investor information was disclosed, although the initial tranche was led by Leucadia National Corp.
2 min read · 13 March 2009
Irving Weissman has joined the technical advisory group of OVP Venture Partners. He is a Stanford University professor who has formed three stem-cell companies: SyStemix Inc., StemCells Inc. and Cellerant Inc.
2 min read · 13 March 2009
Adknowledge, a Kansas City-based provider of behavioral online advertising solutions, has acquired the Media division of MIVA Inc. No financial terms were disclosed. Adknowledge raised $48 million in funding in 2006 from Technology Crossover Ventures.
3 min read · 12 March 2009
2 min read · 12 March 2009
Hunch Inc., a consumer-facing online decision engine, has raised $2 million in Series A funding, according to a regulatory filing. No VC firm names are disclosed, but the company’s board now includes Rob Stavis from Bessemer Venture Partners and Hemant Taneja from General Catalyst. Hunch founder and CEO Chris Dixon was once an associate with Bessemer. www.hunch.com
1 min read · 12 March 2009
Kenta Biotech, a Switzerland-based developer of human monoclonal antibody therapies for serious hospital infections, has raised CHF 12 million ($10m) in Series B funding. No investor information was fisclosed.
3 min read · 12 March 2009
Transera Communications, a Sunnyvale, Calif.-based provider of on-demand virtual contact center software, has raised $17 million in fourth-round funding. Return backers include Accel Partners, Apax Partners, Lighthouse Capital Partners and Storm Ventures. The company previously raised around $30 million.
3 min read · 12 March 2009
RedVision has raised $6.8 million from Edison Venture Fund. The Parsippany, N.J.-based company provides real property research solutions for lenders, title agents/insurers and attorneys.
3 min read · 12 March 2009
George Horner has joined Sofinnova Ventures as an executive-in-residence, according to VentureWire. He is the former CEO of Prestwick Pharmaceuticals, a Sofinnova-backed company sold last year to Biovail Corp. for $100 million in cash. www.sofinnova.com
1 min read · 12 March 2009
Bruce Downey has agreed to join NewSpring Capital as a partner. He previously was chairman and CEO of Barr Pharmaceuticals Inc.
4 min read · 12 March 2009
